Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report
-
By
-
Jifang Zhou
-
Lixia Yu
-
Huimin Xu
-
May 14, 2026
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Massachusetts General Hospital
Boston, MA
Key Differentiators
- Neurology
-
#2
Turku University Hospital
Turku, Finland
Key Differentiators
- Neurology
-
#3
neuropathology laboratory in Gothenburg
Gothenburg, Sweden
Key Differentiators
- Neurology
-
#4
neuromuscular center in Gothenburg
Gothenburg, Sweden
Key Differentiators
- Neurology
-
#5
Peking University First Hospital
Beijing, China
Key Differentiators
- Neurology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.